Enovis Corporation announced it will showcase new products from its recent acquisitions of Novastep and the external fixation assets of D.N.E., LLC, along with its new, organically developed Evolve34 Lapidus Instrumentation, and the new “STAR+ Experience,” Enovis’ Total Ankle System plus patient specific instrumentation, at the American Orthopaedic Foot & Ankle Society(R) annual meeting in Louisville, Kentucky from September 20-23, 2023. Other offerings being showcased for the first time will be Evolve34, a bunion solution for Lapidus correction that allows surgeons to dial in deformity correction and select a hardware construct specific for the patient’s needs. Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail and DynaClip offerings in the hindfoot segment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ENOV:
- Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
- Starboard takes stake in Algonquin Power, exits position in Enovis
- Enovis to Participate in Upcoming Investor Conferences
- Enovis price target raised to $70 from $67 at Baird
- Enovis raises FY23 adjusted EPS view to $2.22-$2.36 from $2.18-$2.32